Changchun changsheng biology science and technology co., ltd. life science institute

The Institute of Life Sciences of Changsheng Biotechnology Co., Ltd. was established in June 2006. It is a wholly-owned subsidiary of Changchun Changsheng Biotechnology Co., Ltd., formerly known as the R&D Center of Changchun Changsheng Biotechnology Co., Ltd., and the Institute of Life Sciences of Changsheng Biotechnology Co., Ltd. has strong independent research and development and new achievements transformation capabilities.

Since its establishment, Changchun Changsheng Biotechnology Co., Ltd. has continuously introduced new products with first-class scientific research strength. Products that have been developed and marketed include rabies vaccine for human use (hamster kidney), rabies vaccine for human use (Vero cells), rabies vaccine for human use without adjuvant (Vero cells) and freeze-dried rabies vaccine for human use (Vero cells), freeze-dried live attenuated hepatitis A vaccine, split influenza vaccine, freeze-dried live attenuated varicella vaccine and adsorbed cell-free DTP combined vaccine.

At present, the company has independently developed 9- 10 research and development projects including bacterial vaccines, virus vaccines and genetic engineering products.

The company's average annual investment in R&D is10 million yuan. The research institute is affiliated to the company and operates independently, and the scientific research results developed are owned by the head office. At present, the Institute of Life Sciences has signed an agreement with domestic authoritative scientific research institutions to jointly develop new products, laying the foundation for subsequent products to be introduced to the market one after another.

Since its establishment, the Institute has integrated the original resources and built several R&D platforms. Well-equipped equipment and professional talents, using the corresponding R&D platform after the project is established, can shorten the preparation time of the project opening, save R&D costs and improve work efficiency. Establish three research centers, with the research institute as the core, and the research projects rely on the research and development platform to improve the overall research and development level. The first product of an enterprise is talents, and high-quality researchers are the core of research and development. At the same time, the institute also has a group of high-quality biotechnology experts and technical backbones, including more than 50 R&D staff, all of whom have bachelor degree or above. The Institute also hired famous domestic scholars and academicians of the Chinese Academy of Sciences as technical consultants to guide the smooth implementation of scientific research projects.

Life science research has a director and a project leader. Specific management and responsibilities include plan management, project management, fund management, achievement management, scientific and technological cooperation, scientific and technological awards, scientific and technological confidentiality, clinical observation, new drug application and academic exchange. The management of the institute is a talented team with enterprising spirit, sense of responsibility, technical knowledge and management skills.